| Deler fremragende | 89,353,773 shares |
| Insideraktier | 13.184.962 shares |
| Insider ejerskab | 14,76 % |
| Total Insiders | 16 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Cognition Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
BIOS Fund III NT, LP
10% Owner -
|
1.424.014 | 6.048.500 | |
|
BIOS Memory SPV I, LP
10% Owner -
|
1.424.014 | 6.048.500 | |
|
Bios Clinical Opportunity Fund, LP
Director, 10% Owner -
[D]
|
1.000.190 | 1.000.190 | |
| Breedlove Mark H. Director - [D] | 404.439 | 404.439 | |
| Anthony Caggiano Chief Medical Officer - [O] | 874.906 | 874.906 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| John Brendan Doyle Chief Financial Officer - [O] | 627.509 | 627.509 | |
|
Fletcher Aaron G.L.
Director, 10% Owner -
[D]
|
56.229 | 56.229 | |
|
Golden Seeds Cognition Therapeutics LLC
10% Owner -
|
0 | 0 | |
| Khattar Jack A. Director - [D] | 48.500 | 48.500 | |
|
Kreis Leslie W.
10% Owner -
|
6.048.500 | 6.048.500 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Brett P Monia Director - [D] | 48.500 | 48.500 | |
| James Michael O'Brien Chief Financial Officer - [O] | 5.000 | 5.000 | |
|
Ogden CAP Associates, LLC
10% Owner -
|
2.210.377 | 2.210.377 | |
| Ellen B Richstone Director - [D] | 58.500 | 58.500 | |
| Lisa Ricciardi CEO & President, Director - [D] [O] | 1.715.851 | 1.715.851 | |
| Peggy Wallace Director - [D] | 86.461 | 86.461 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CGTX / Cognition Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CGTX / Cognition Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-20 | 2026-04-16 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,1300 | 10.000 | 11 | 627.509 | ||||
| 2026-04-20 | 2026-04-16 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,1000 | 9.175 | 10 | 1.715.851 | ||||
| 2026-04-20 | 2026-04-16 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 1,1100 | 10.000 | 11 | 874.906 | ||||
| 2026-02-18 | 2026-02-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,1200 | -5.850 | -7 | 1.706.676 | ||||
| 2026-02-18 | 2026-02-15 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,1200 | -1.560 | -2 | 617.509 | ||||
| 2026-02-18 | 2026-02-15 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 1,1200 | -4.680 | -5 | 864.906 | ||||
| 2026-02-05 | 2026-02-04 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,0300 | -51.704 | -53 | 1.712.526 | ||||
| 2026-02-05 | 2026-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,1200 | -26.036 | -29 | 1.764.230 | ||||
| 2026-02-05 | 2026-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 800.000 | 1.790.266 | ||||||
| 2026-02-05 | 2026-02-04 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,0300 | -26.921 | -28 | 619.069 | ||||
| 2026-02-05 | 2026-02-03 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 200.000 | 645.990 | ||||||
| 2026-02-05 | 2026-02-04 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 1,0300 | -26.919 | -28 | 869.586 | ||||
| 2026-02-05 | 2026-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 1,1200 | -11.488 | -13 | 896.505 | ||||
| 2026-02-05 | 2026-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 400.000 | 907.993 | ||||||
| 2025-12-22 | 2025-12-18 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,5000 | -23.400 | -35 | 990.266 | ||||
| 2025-12-22 | 2025-12-18 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 75.000 | 1.013.666 | ||||||
| 2025-12-22 | 2025-12-18 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,5000 | -9.360 | -14 | 445.990 | ||||
| 2025-12-22 | 2025-12-18 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 30.000 | 455.350 | ||||||
| 2025-12-22 | 2025-12-18 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 1,5000 | -20.280 | -30 | 507.993 | ||||
| 2025-12-22 | 2025-12-18 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 65.000 | 528.273 | ||||||
| 2025-09-23 | 2025-09-19 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 0,8400 | 7.729 | 6 | 56.229 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,6702 | -9.360 | -6 | 425.350 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 30.000 | 434.710 | ||||||
| 2025-07-31 | 2025-07-29 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,6702 | -20.281 | -14 | 463.273 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 65.000 | 483.554 | ||||||
| 2025-07-31 | 2025-07-29 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,6702 | -23.400 | -16 | 938.666 | ||||
| 2025-07-31 | 2025-07-29 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 75.000 | 962.066 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 34.000 | 48.500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Monia Brett P | CGTX | Common Stock | D | 34.000 | 48.500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 34.000 | 58.500 | ||||||
| 2025-06-23 | 2025-06-18 | 4 | Wallace Peggy | CGTX | Common Stock | D | 34.000 | 86.461 | ||||||
| 2025-06-20 | 2025-06-18 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 34.000 | 48.500 | ||||||
| 2025-06-20 | 2025-06-18 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 34.000 | 48.500 | ||||||
| 2025-05-02 | 2025-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,4472 | -9.692 | -4 | 404.710 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,5901 | -6.619 | -4 | 887.066 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 0,5901 | -1.723 | -1 | 414.402 | ||||
| 2025-02-18 | 2025-02-15 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,5901 | -5.296 | -3 | 418.554 | ||||
| 2025-02-04 | 2025-02-04 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 295.000 | 416.125 | ||||||
| 2025-02-04 | 2025-02-04 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 295.000 | 423.850 | ||||||
| 2025-02-04 | 2025-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 0,6660 | -12.779 | -9 | 128.850 | ||||
| 2025-02-04 | 2025-02-04 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 631.300 | 893.685 | ||||||
| 2025-02-04 | 2025-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 0,6660 | -28.960 | -19 | 262.385 | ||||
| 2025-02-04 | 2025-01-31 | 4 | Ricciardi Lisa By Spouse | CGTX | Common Stock | I | 0,7722 | 38.851 | 30 | 38.851 | ||||
| 2024-06-11 | 2024-06-07 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 8.500 | 14.500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 8.500 | 14.500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Wallace Peggy | CGTX | Common Stock | D | 8.500 | 52.461 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 8.500 | 24.500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 8.500 | 14.500 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Monia Brett P | CGTX | Common Stock | D | 8.500 | 14.500 | ||||||
| 2024-05-03 | 2024-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 1,9500 | -8.699 | -17 | 121.125 | ||||
| 2024-03-14 | 2024-03-14 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,7500 | 5.700 | 10 | 291.345 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 60.000 | 141.629 | ||||||
| 2024-02-20 | 2024-02-15 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 20.000 | 129.824 | ||||||
| 2024-02-20 | 2024-02-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 75.000 | 285.645 | ||||||
| 2024-02-09 | 2024-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 2,2900 | -12.777 | -29 | 81.629 | ||||
| 2024-02-09 | 2024-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 2,2900 | -27.828 | -64 | 210.645 | ||||
| 2023-11-13 | 3 | Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | D | 500.095 | ||||||||
| 2023-11-13 | 2023-11-08 | 4 | Fletcher Aaron G.L. By Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | I | 1,0500 | 500.095 | 525 | 500.095 | ||||
| 2023-11-13 | 2023-11-08 | 4 | Kreis Leslie W. By Bios Clinical Opportunity Fund, LP | CGTX | Common Stock | I | 1,0500 | 500.095 | 525 | 500.095 | ||||
| 2023-06-13 | 2023-06-09 | 4 | Kreis Leslie W. | CGTX | Common Stock | I | 6.000 | 6.000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Fletcher Aaron G.L. | CGTX | Common Stock | D | 6.000 | 6.000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Wallace Peggy | CGTX | Common Stock | D | 6.000 | 43.961 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Monia Brett P | CGTX | Common Stock | D | 6.000 | 6.000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | Khattar Jack A. | CGTX | Common Stock | D | 6.000 | 6.000 | ||||||
| 2023-06-13 | 2023-06-09 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 6.000 | 16.000 | ||||||
| 2023-05-03 | 2023-05-01 | 4 | Doyle John Brendan | CGTX | Common Stock | D | 109.824 | 109.824 | ||||||
| 2023-02-07 | 2023-02-03 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 213.973 | 238.473 | ||||||
| 2023-02-07 | 2023-02-03 | 4 | Caggiano Anthony | CGTX | Common Stock | D | 94.406 | 94.406 | ||||||
| 2022-11-29 | 2022-11-29 | 4 | RICHSTONE ELLEN B | CGTX | Common Stock | D | 2,6550 | 10.000 | 27 | 10.000 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP | CGTX | Common Stock | I | 2,6497 | 1.871 | 5 | 309.748 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 2,6497 | 12.220 | 32 | 2.021.906 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 2,6497 | 1.973 | 5 | 326.733 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III, LP | CGTX | Common Stock | I | 2,6497 | 1.871 | 5 | 309.748 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 2,6497 | 12.220 | 32 | 2.021.906 | ||||
| 2022-11-29 | 2022-11-28 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 2,6497 | 1.973 | 5 | 326.733 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. Bios Fund III, LP | CGTX | Common Stock | I | 1,4000 | 8.269 | 12 | 307.877 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,4000 | 54.009 | 76 | 2.009.686 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,4000 | 8.722 | 12 | 324.760 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. Bios Fund III, LP | CGTX | Common Stock | I | 1,4000 | 8.269 | 12 | 307.877 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,4000 | 54.009 | 76 | 2.009.686 | ||||
| 2022-11-17 | 2022-11-16 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,4000 | 8.722 | 12 | 324.760 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Wallace Peggy | CGTX | Common Stock | D | 1,2000 | 12.500 | 15 | 37.961 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 1,3000 | 12.000 | 16 | 24.500 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. Bios Fund III, LP | CGTX | Common Stock | I | 1,2000 | 174.700 | 210 | 299.608 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,2000 | 1.141.030 | 1.369 | 1.955.677 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Fletcher Aaron G.L. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,2000 | 184.270 | 221 | 316.038 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. Bios Fund III, LP | CGTX | Common Stock | I | 1,2000 | 174.700 | 210 | 299.608 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. By Bios Fund III QP, LP | CGTX | Common Stock | I | 1,2000 | 1.141.030 | 1.369 | 1.955.677 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Kreis Leslie W. By Bios Fund III NT, LP | CGTX | Common Stock | I | 1,2000 | 184.270 | 221 | 316.038 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | -2.489.682 | 0 | ||||||
| 2022-09-29 | 2022-09-27 | 4 | Wallace Peggy | CGTX | Common Stock | D | 22.461 | 25.461 | ||||||
| 2022-03-25 | 2022-03-23 | 4 | O'Brien James Michael | CGTX | Stock Option (right to buy) | D | 3,05 | 50.000 | 50.000 | |||||
| 2022-03-25 | 2022-03-23 | 4 | Caggiano Anthony | CGTX | Stock Option (right to buy) | D | 3,05 | 25.000 | 25.000 | |||||
| 2022-02-01 | 2022-01-31 | 4 | Fletcher Aaron G.L. By BP Directors, LP | CGTX | Stock Option (right to buy) | I | 1,75 | 1.145 | 1.145 | |||||
| 2022-02-01 | 2022-01-31 | 4 | Fletcher Aaron G.L. | CGTX | Stock Option (right to buy) | D | 1,75 | -1.145 | 2.719 | |||||
| 2022-02-01 | 2021-10-13 | 4/A | BIOS Memory SPV I, LP | CGTX | Common Stock | D | 1.424.014 | 1.424.014 | ||||||
| 2022-02-01 | 2021-10-13 | 4/A | Fletcher Aaron G.L. By Bios Memory SPV I, LP | CGTX | Common Stock | I | 1.424.014 | 1.424.014 | ||||||
| 2021-11-10 | 2021-11-01 | 4 | Caggiano Anthony | CGTX | Stock Option (right to buy) | D | 12,10 | 161.676 | 161.676 | |||||
| 2021-11-03 | 2021-11-01 | 4 | RICHSTONE ELLEN B | CGTX | Stock Option (right to buy) | D | 12,10 | 16.670 | 16.670 | |||||
| 2021-10-25 | 2021-10-13 | 4 | Wallace Peggy | CGTX | Common Stock | D | 12,0000 | 3.000 | 36 | 3.000 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Simple Agreement for Future Equity | I | -25.593 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Simple Agreement for Future Equity | I | -158.476 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Simple Agreement for Future Equity | I | -24.263 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Warrant (right to buy) | I | 0,03 | -33.495 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -111.504 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -1.930.673 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -134.626 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -110.744 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -1.138.040 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -827.275 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -253.256 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, QP, LP. | CGTX | Series B Convertible Preferred Stock | I | -792.547 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, LP. | CGTX | Series B Convertible Preferred Stock | I | -1.355.017 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP | CGTX | Series B Convertible Preferred Stock | D | -4.605.985 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 25.593 | 60.065 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 34.472 | 34.472 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 12,0000 | 144.530 | 1.734 | 899.905 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 158.476 | 755.375 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 596.899 | 596.899 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 12,0000 | 22.129 | 266 | 88.012 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 24.263 | 65.883 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund III, LP. | CGTX | Common Stock | I | 41.620 | 41.620 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 12,0000 | -90 | -1 | 385.248 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 0,0320 | 33.495 | 1 | 385.339 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 351.844 | 351.844 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 12,0000 | 23.341 | 280 | 57.579 | ||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 34.238 | 34.238 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, QP, LP. | CGTX | Common Stock | I | 255.765 | 255.765 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund II, LP. | CGTX | Common Stock | I | 78.298 | 78.298 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, QP, LP. | CGTX | Common Stock | I | 245.029 | 245.029 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP By Bios Fund I, LP. | CGTX | Common Stock | I | 418.926 | 418.926 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | BIOS Memory SPV I, LP | CGTX | Common Stock | D | 1.424.014 | 1.424.014 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Warrant (right to buy) | D | 0,03 | -27.471 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series B-1 Convertible Preferred Stock | D | -438.854 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series B Convertible Preferred Stock | D | -4.087.046 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A-2 Convertible Preferred Stock | D | -882.233 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A-1 Convertible Preferred Stock | D | -333.333 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Series A Convertible Preferred Stock | D | -1.319.408 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 12,0000 | -74 | -1 | 2.210.377 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 0,0320 | 27.471 | 1 | 2.210.452 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 135.679 | 2.182.981 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 1.263.575 | 2.047.302 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 272.756 | 783.727 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 103.055 | 510.971 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Ogden CAP Associates, LLC | CGTX | Common Stock | D | 407.916 | 407.916 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series A-1 Convertible Preferred Stock | D | -884.058 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Simple Agreement for Future Equity | D | 0 | |||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Warrant (right to buy) | D | 0,03 | -12.276 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series B-1 Convertible Preferred Stock | D | -1.574.370 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series B Convertible Preferred Stock | D | -4.004.181 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Series A-2 Convertible Preferred Stock | D | -542.496 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 311.706 | 2.489.691 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 12,0000 | -33 | -0 | 2.177.985 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 0,0320 | 12.276 | 0 | 2.178.019 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 486.742 | 2.165.743 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 1.237.959 | 1.679.001 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 167.721 | 441.042 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Golden Seeds Cognition Therapeutics LLC | CGTX | Common Stock | D | 273.321 | 273.321 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Simple Agreement for Future Equity | I | -25.593 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Simple Agreement for Future Equity | I | -158.476 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Simple Agreement for Future Equity | I | -24.263 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Warrant (right to buy) | I | 0,03 | -33.495 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -111.504 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -1.930.673 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -134.626 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -110.744 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -1.138.040 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, QP, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -827.275 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP. | CGTX | Series B-1 Convertible Preferred Stock | I | -253.256 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, QP, LP. | CGTX | Series B Convertible Preferred Stock | I | -792.547 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP. | CGTX | Series B Convertible Preferred Stock | I | -1.355.017 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. | CGTX | Series B Convertible Preferred Stock | D | -4.605.985 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 25.593 | 60.065 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, NT, LP. | CGTX | Common Stock | I | 34.472 | 34.472 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 12,0000 | 144.530 | 1.734 | 899.905 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 158.476 | 755.375 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, QP, LP. | CGTX | Common Stock | I | 596.899 | 596.899 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 12,0000 | 22.129 | 266 | 88.012 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 24.263 | 65.883 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund III, LP. | CGTX | Common Stock | I | 41.620 | 41.620 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 12,0000 | -90 | -1 | 385.248 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 0,0320 | 33.495 | 1 | 385.339 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV II, LP. | CGTX | Common Stock | I | 351.844 | 351.844 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 12,0000 | 23.341 | 280 | 57.579 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, NT, LP. | CGTX | Common Stock | I | 34.238 | 34.238 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, QP, LP. | CGTX | Common Stock | I | 255.765 | 255.765 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund II, LP. | CGTX | Common Stock | I | 78.298 | 78.298 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, QP, LP. | CGTX | Common Stock | I | 245.029 | 245.029 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Fund I, LP. | CGTX | Common Stock | I | 418.926 | 418.926 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Fletcher Aaron G.L. By Bios Memory SPV I, LP. | CGTX | Common Stock | I | 1.424.014 | 1.424.014 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Warrant (Right to Buy) | I | 0,03 | -4.354 | 0 | |||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series B-1 Convertible Preferred Stock | I | -301.978 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series B Convertible Preferred Stock | I | -826.278 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series A-2 Convertible Preferred Stock | I | -118.835 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Series A-1 Convertible Preferred Stock | I | -144.928 | 0 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 12,0000 | -12 | -0 | 404.439 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 0,0320 | 4.354 | 0 | 404.451 | ||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 93.296 | 400.097 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 225.281 | 306.801 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 36.714 | 81.520 | ||||||
| 2021-10-15 | 2021-10-13 | 4 | Breedlove Mark H. By Breedlove Family Limited Partnership. | CGTX | Common Stock | I | 44.806 | 44.806 | ||||||
| 2021-10-14 | 2021-10-13 | 4 | Ricciardi Lisa | CGTX | Common Stock | D | 12,0000 | 12.500 | 150 | 12.500 | ||||
| 2021-10-14 | 2021-10-13 | 4 | O'Brien James Michael | CGTX | Common Stock | D | 12,0000 | 5.000 | 60 | 5.000 | ||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 290.509 | 290.509 | |||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 290.509 | 290.509 | |||||
| 2021-10-12 | 2021-10-07 | 4 | Ricciardi Lisa | CGTX | Stock Option (right to buy) | D | 12,00 | 547.965 | 547.965 | |||||
| 2021-10-12 | 2021-10-07 | 4 | O'Brien James Michael | CGTX | Stock Option (right to buy) | D | 12,00 | 54.457 | 54.457 | |||||
| 2021-10-07 | 3 | Breedlove Mark H. | CGTX | Common Stock | D | 7.611 |
